Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A. Upadhyaya, Amar Gajjar, Anne Bendel et al.|Neuro-Oncology|2022Cited by 29
Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by warAsya Agulnik, Sarah Weeks Alexander, Yuliya Nogovitsyna et al.|The Lancet Haematology|2022Cited by 26
Resilient health care in global pediatric oncology during the COVID‐19 pandemicDylan E. Graetz, Daniela Arce, Elizabeth Sniderman et al.|Cancer|2021Cited by 23